Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03773484 · ClinicalTrials.gov registry record · NA
Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase
A NA study of Opioid Use, Unspecified, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT03773484: Completed NA study of Opioid Use, Unspecified, sponsored by University of Southern California.
NCT03773484 is a NA study of Opioid Use, Unspecified that has completed, run by University of Southern California. The registered enrollment target is 41 participants, below the 223-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03773484, a NA study of Opioid Use, Unspecified, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
There is a lack of evidence that long-term opioid use offers benefit for noncancer pain and an abundance of evidence of harm. The objective of the R21 pilot phase of the Application of Economics \& Social psychology to improve Opioid Prescribing Safety (AESOPS) is to develop and test novel behavioral nudges to encourage adherence to pain and CDC guidelines for opioid prescribing for persons with noncancer pain. Interventions will leverage the electronic health record (EHR) to discourage unnecessary opioid prescribing through the application of "behavioral insights"-empirically-tested social and psychological interventions that affect choice.
Primary Outcome
Average per-clinician weekly milligram morphine equivalent (MME) in the 34-week period post-intervention
Conditions Studied
Interventions
- BEHAVIORAL Long-term opioid recipient
- BEHAVIORAL Opioid naive
- BEHAVIORAL At-risk for long term use
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-03-25 |
| Est. Completion | 2019-11-30 |
| Phase | NA |
What the finished NCT03773484 record still lists
NCT03773484 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 223-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Opioid Use, Unspecified appearing as the primary indexed condition, and to 3 interventions - of which Long-term opioid recipient is the first listed.
NCT03773484 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03773484 about?
NCT03773484 is a clinical study titled "Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase". There is a lack of evidence that long-term opioid use offers benefit for noncancer pain and an abundance of evidence of harm. The objective of the R21 pilot phase of the Application of Economics \& Social psychology to improve Opioid Prescribing Safety (AESOPS) is to develop and test novel behaviora...
What is the current status of trial NCT03773484?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-03-25. Estimated completion is 2019-11-30.
What conditions does trial NCT03773484 study?
This clinical trial studies the following conditions: Opioid Use, Unspecified.
What interventions are being tested in trial NCT03773484?
The interventions under investigation include: Long-term opioid recipient (BEHAVIORAL), Opioid naive (BEHAVIORAL), At-risk for long term use (BEHAVIORAL).
Who is sponsoring clinical trial NCT03773484?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03773484 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use, Unspecified
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03773484's enrollment target sits among peer trials
41 8th of 9 higher than 2 of 9 other Opioid Use, Unspecified trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use, Unspecified trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Utilization of Opioid Destruction Bags in the Post-op Period
ACTIVE NOT RECRUITING · NA
-
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
COMPLETED · NA
-
EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use
COMPLETED · NA
-
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
COMPLETED · NA
-
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
RECRUITING
-
Sensory Outcomes in Active Substance Users
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI